Advances in the treatment of Ewing's sarcoma have been dramatic. Present treatment protocols control local disease by radiotherapy, surgery, or both; systemic spread is limited by aggressive multiagent chemotherapy. In patients with localized osseous Ewing's sarcoma, five-year survival rates now range from 54% to an estimated 74%. With late relapse not uncommon, control of the primary lesion is critical to long-term survival. Several studies now show improved local control and possibly improved survival of patients with surgical treatment of primary osseous Ewing's sarcoma.
|Original language||English (US)|
|Number of pages||10|
|Journal||Clinical orthopaedics and related research|
|State||Published - Jan 1 1991|
ASJC Scopus subject areas
- Orthopedics and Sports Medicine